Scintigraphy for risk stratification of iodine-induced thyrotoxicosis in patients receiving contrast agent for coronary angiography: A prospective study of patients with low thyrotropin

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 12, 2004, Pages 6092-6096

  Fricke, Eva ^a   Fricke, Harald ^a   Esdorn, Elke ^a   Kammeier, Annett ^a   Lindner, Oliver ^a   Kleesiek, Knut ^a   Horstkotte, Dieter ^a   Burchert, Wolfgang ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IODINATED CONTRAST MEDIUM; IOPROMIDE; PERCHLORATE; TECHNETIUM 99M; THYROTROPIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTOXICOSIS;

AGED; ANTITHYROID AGENTS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; INCIDENCE; IODINE; MALE; METHIMAZOLE; MIDDLE AGED; PERCHLORIC ACID; PROSPECTIVE STUDIES; RISK ASSESSMENT; TECHNETIUM; THYROID GLAND; THYROTOXICOSIS; THYROTROPIN;

EID: 10344245524     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0728     Document Type: Article

References (24)

1. Rendl J, Saller B 2001 Schilddruese und Roentgenkontrastmittel. Deutsches Aerzteblatt 7:402-406
2. Sergeev PV, Belykh AG 1982 [Effect of contrast agents on the iodine-absorbing function of the thyroid gland]. Farmakol Toksikol 45:96-100 (Russian)
3. Talner LB, Coel MN, Lang JH 1973 Salivary secretion of iodine after urography. Further evidence for in vivo deiodination and salivary secretion of contrast media. Radiology 106:263-268
4. Conn JJ, Sebastian MJ, Deam D, Tam M, Martin FI 1996 A prospective study of the effect of nonionic contrast media on thyroid function. Thyroid 6:107-110
5. de Bruin TW 1994 Iodide-induced hyperthyroidism with computed tomography contrast fluids. Lancet 343:1160-1161
6. Fassbender WJ, Schlueter S, Stracke H, Bretzel RG, Waas W, Tillmanns H 2001 [Thyroid function after iodine-containing contrast agent administration in coronary angiography: a prospective study of euthyroid patients]. Z Kardiol 90:751-759 (German)
7. Hintze G, Blombach O, Fink H, Burkhardt U, Kobberling J 1999 Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol 140:264-267
8. Emrich D, Erlenmaier U, Pohl M, Luig H 1993 Determination of the autonomously functioning volume of the thyroid. Eur J Nucl Med 20:410-414
9. Kreisig T, Pickardt CR, Horn K, Stalla G, Willemsen F, Knesewitsch P 1992 TcTUs zur Abschätzung des Hyperthyreoserisikos nach Jodkontamination von euthyreoten Strumapatienten mit kompensierter Autonomie. In: Roeher H-D, Weinheimer B, eds. Schilddruese 1991. Berlin, New York: de Gruyter; 393-399
10. Meller J, Becker W 1998 Scintigraphic evaluation of functional thyroidal autonomy. Exp Clin Endocrinol Diabetes 106:S45-S51
11. Meller J, Becker W 1999 Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy. Q J Nucl Med 43:179-187
12. Dietlein M, Dressler J, Eschner W, Leisner B, Reiners C, Schicha H 2003 [Procedure guideline for thyroid scintigraphy (version 2)]. Nuklearmedizin 42:120-122 (German)
13. Bundesaerztekammer 2003 Richtlinie der Bundesaertzekammer zur Qualitaetssicherung laboratoriumsmedizinischer Untersuchungen. Deutsches Aerzteblatt 50:A3335-A3338
14. Wawschinek O, Eber O, Petek W, Wakonig P, Gürakar A 1985 Bestimmung der Harnjodausscheidung mittels einer modifizierten Cer-Arsenitmethode. Ber OGKC Jahrgang 8:13-15
15. Joseph K 1994 Estimation of the volume of autonomously functioning thyroid tissue. Exp Clin Endocrinol 102:12-19
16. Schneider D, Joseph K, Hoeffken H, Kuemmel H, Nebe R, Skamel H-J, Stapp J, Welke U 1992 Werden Patienten mit funktioneller thyreoidaler Autonomie durch Optimierung der taeglichen Jodzufuhr gefaehrdet? In: Roeher H-D, Weinheimer B, eds. Schilddruese 1991. Berlin, New York: de Gruyter; 400-404
17. Gessl A, Raber W 2002 Schilddruese und Herz. Z Kardiol 91:125-128
18. Kahaly GJ, Nieswandt J, Mohr-Kahaly S 1998 Cardiac risks of hyperthyroidism in the elderly. Thyroid 8:1165-1169
19. Schumm-Draeger P-M, Usadel K, Senekowitsch R 1989 Effekt einer thyreostatischen Therapie bei iodinduzierter Hyperthyreose - Untersuchungen an xenotransplantierten Geweben immunogener sowie nicht immunogener Hyperthyreoseformen. In: Pickardt CR PP, Weinheimer B, eds. Schilddruese 1987. Stuttgart, New York: Thieme-Verlag; 253-258
20. Fritzsche H, Benzer W, Furlan W 1992 Praevention jodinduzierter Hyperthyreosen bei Koronarangiographie. In: Roeher H-D, Weinheimer B, eds. Schilddruese 1991. Berlin, New York: de Gruyter; 406-413
21. Fritzsche H, Benzer W, Furlan W, Hammerle D, Langsteger W, Weiss P 1993 Prevention of iodine-induced hyperthyroidism after coronary angiography. Acta Med Austriaca 20:13-17 (German)
22. Nolte W, Muller R, Siggelkow H, Emrich D, Hufner M 1996 Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 134:337-341
23. Wolf J 1998 Perchlorate and the thyroid gland. Pharmacol Rev 50:89-105
24. Molnar I 2000 Systemic adverse effect of antithyroid drugs. Clin Rheumatol 19:78